Veterinary PoC Diagnostics Market

The veterinary PoC diagnostics market is projected to reach USD 1.72 billion by 2031 from USD 1.19 billion in 2026, growing at a CAGR of 7.7%.

The veterinary PoC diagnostics market is flourishing, mainly because extensive poultry-based production systems are demanding fast and reliable means of disease identification. The incidences of bird flu and other highly contagious viral infections, such as Newcastle disease and infectious bronchitis, have drastically increased the need for early detection, frequent flock screening, and continuous disease surveillance. Diagnostic techniques such as PCR, ELISA, and other automated high-throughput diagnostic systems have not only enhanced the speed but also the accuracy of pathogen detection. In addition, the booming commercial poultry sector, increasing global consumption of poultry and eggs, along with stricter biosecurity and food safety regulations, are leading poultry farmers and veterinary laboratories to opt for more advanced diagnosing solutions. As a result, the veterinary PoC diagnostics market is experiencing uninterrupted growth in line with its finding ways to support a healthy human diet through animal protein intensification.

To know about the assumptions considered for the study download the pdf brochure

The prominent players in the veterinary PoC diagnostics market are IDEXX Laboratories, Inc. (US), Zoetis Services LLC (US), Antech Diagnostics, Inc. (US), Thermo Fisher Scientific Inc. (US), Virbac (France), among others. These companies have implemented a variety of growth strategies, both organic and inorganic, including the introduction of new products, the formation of strategic partnerships, and penetration into emerging markets. These initiatives are aimed at enhancing their market share and diversifying their portfolios.

In April 2026, Zoetis Services LLC (US) announced the expansion of its Vetscan OptiCell point-of-care hematology analyzer, adding new parameters such as cellular hemoglobin concentration mean (CHCM) and plateletcrit (PCT), enhancing in-clinic diagnostic depth and enabling more advanced real-time blood analysis.
Similarly, in June 2025, bioMérieux (France) launched VETFIRE, a ready-to-use PCR kit specifically made for equine infectious respiratory diseases. It helps in the simultaneous detection of seven infectious respiratory pathogens in horses.

IDEXX Laboratories, Inc. is an animal health diagnostics company with a strong presence in the veterinary point-of-care (PoC) diagnostics market, primarily driven by its Companion Animal Group (CAG) segment. This segment offers a comprehensive portfolio of in-clinic diagnostic solutions, including the IDEXX VetLab suite (chemistry, hematology, urinalysis, immunodiagnostics, and cytology analyzers) and SNAP rapid tests for immediate disease detection during patient visits. While the Livestock, Poultry & Dairy (LPD) segment also contributes through diagnostic tests and monitoring solutions for herd and flock health, it is more focused on laboratory and production-level testing rather than core PoC applications. IDEXX’s PoC ecosystem is further supported by digital platforms such as VetLab Station and VetConnect PLUS, and complemented by reference laboratory services and software offerings, with operations spanning over 175 countries worldwide.

Zoetis Services LLC is an animal health company engaged in the research, development, manufacturing, and commercialization of a wide range of products, including medicines, vaccines, diagnostics, biodevices, and genetic tests for both companion animals and livestock. Within the veterinary point-of-care (PoC) diagnostics market, Zoetis offers in-clinic diagnostic solutions under its diagnostics portfolio, including the VetScan range of analyzers for chemistry, hematology, and immunodiagnostics, along with rapid testing capabilities that support immediate clinical decision-making. These PoC solutions are complemented by digital platforms such as Vetscan Imagyst, which integrates AI-based diagnostic analysis for applications such as fecal testing and cytology. The company operates through US and International segments and maintains a strong global presence, with operations in approximately 45 countries and product sales in over 100 countries, supported by an extensive distribution and subsidiary network.

Market Ranking

The top 5 companies of the veterinary PoC diagnostics market are IDEXX Laboratories, Inc. (US), Zoetis Services LLC (US), Antech Diagnostics, Inc. (US), Thermo Fisher Scientific Inc. (US), and Virbac (France). IDEXX Laboratories, Inc. provides advanced in-clinic PoC diagnostic solutions, including VetLab analyzers and SNAP rapid tests, enabling real-time disease detection and clinical decision-making; Zoetis Services LLC offers VetScan analyzers and AI-enabled platforms, including Vetscan Imagyst, to support rapid and accurate in-clinic diagnostics; Antech Diagnostics, Inc. delivers integrated PoC diagnostic solutions with in-house analyzers, rapid tests, and AI-driven tools to enhance workflow and diagnostic accuracy; Thermo Fisher Scientific Inc. supplies PCR-based molecular platforms and portable diagnostic systems for rapid and precise pathogen detection in decentralized settings; Virbac provides rapid immunodiagnostic kits and PoC testing solutions for infectious and parasitic diseases, supporting routine screening and preventive veterinary care.

Related Reports:

Veterinary PoC Diagnostics Market by Product (Consumables and Instruments), Technology [Immunodiagnostics, Molecular Diagnostics (Isothermal Amplification, PCR, CRISPR)], Animal Type (Companion Animals, Livestock, Poultry) - Global Forecast to 2031

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]